These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 156920)

  • 1. [Comparative characteristics of the fibrinolytically active fractions obtained from the blood plasma of those who have died suddenly].
    Platonova TK; Khvatov VB
    Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):47-50. PubMed ID: 156920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of human plasminogen activator and of a fraction of fibrinolytically active plasma enriched with this enzyme].
    Plastonova TK; Petrenko OA
    Vopr Med Khim; 1979; 25(3):302-7. PubMed ID: 156462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical substantiation of the expediency of using the euglobulin fractions of blood plasma from persons who died suddenly for obtaining the preparations of fibrinolytic action].
    Khvatov VB; Platonova TK
    Probl Gematol Pereliv Krovi; 1976 Mar; 21(3):38-42. PubMed ID: 136655
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of endogenous fibrinolysis activation on human plasminogen].
    Platonova TK; Kalashnikov VV; Khvatov VB
    Biull Eksp Biol Med; 1987 Jan; 103(1):59-61. PubMed ID: 2432967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of myocardial infarct with fibrinolytically active plasma obtained from the blood of patients having died suddenly].
    Smetnev AS; Petrova LI; Pafomov GA; Zykova KI; Ivashchenko AG
    Ter Arkh; 1973 Aug; 45(8):14-9. PubMed ID: 4777140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation and characteristics of fibronectin from fibrinolytically active human plasma].
    Litvinov RI; Khvatov VB; Shakirov KT; Abdullin AR; Solov'eva IZ
    Vopr Med Khim; 1991; 37(5):47-9. PubMed ID: 1759396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Separation of plasminogen and plasmin by DEAE Sephadex A-50 column chromatography].
    Tozawa Y; Ota E
    Rinsho Byori; 1970 Aug; 18(8):571-4. PubMed ID: 4248205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Obtaining active plasminogen from the blood plasma of those who have died suddenly].
    Petrenko OA; Khvatov VB
    Probl Gematol Pereliv Krovi; 1976 Dec; 21(12):46-8. PubMed ID: 1024207
    [No Abstract]   [Full Text] [Related]  

  • 10. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the purification and characterization of human urinary plasminogen and plasmin.
    Chen HF; Nakabayashi M; Satoh K; Sakamoto S
    Thromb Haemost; 1980 Feb; 42(5):1536-47. PubMed ID: 6445089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A method for determining plasmin by the rate of fibrin gel lysis].
    Popova GIu; Eremeev NL; Aĭsina RB; Kazanskaia NF
    Biull Eksp Biol Med; 1989 May; 107(5):561-4. PubMed ID: 2525408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic standards and assay methods--1967-1968.
    Johnson AJ; Kline DL; Alkjaersig N
    Thromb Diath Haemorrh Suppl; 1968; 35():185-7. PubMed ID: 4269140
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on fluidity of blood on the basis of fibrinolysis. 6. Relationship of fluidity to plasmin of blood in sudden and instantaneous deaths and also those from asphyxiation].
    Ueno S
    Nihon Hoigaku Zasshi; 1969 Mar; 23(2):98-116. PubMed ID: 4242779
    [No Abstract]   [Full Text] [Related]  

  • 15. The significance of plasma inhibitor(s) in the control of fibrinolytic (plasmin) activity in blood.
    Monkhouse FC; Milojevic S; Schmitt A
    Thromb Diath Haemorrh; 1972 Dec; 28(3):367-75. PubMed ID: 4265318
    [No Abstract]   [Full Text] [Related]  

  • 16. A rapid and sensitive analytical procedure for human plasminogen subspecies. Combination of high-performance affinity chromatography and specific monitoring of proenzymes.
    Ito N; Abe I; Noguchi K; Kazama M; Shimura K; Kasai K
    Biochem Int; 1987 Aug; 15(2):311-9. PubMed ID: 2963638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and properties of acylplasmin].
    Aĭsina RB; Kazanskaia NF; Andreenko GV; Liutova LV; Pén'ia K
    Vopr Med Khim; 1985; 31(4):30-4. PubMed ID: 2931900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of human plasminogen with deoxyribonucleic acids. II. Protection of human plasminogen against catalytic activation with deoxyribonucleic acids.
    Hakim AA
    Enzymologia; 1970 Jan; 38(1):57-81. PubMed ID: 4244649
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
    Berg W
    Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.